Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
MMP9 degrades type IV and V collagens
It belongs
including myofibril necrosis in myopathies and in myocardial ischemia
patent Anti-Nav1
Anti-human VEGFR1 / FLT1 (Abbott patent Anti-Flt1 Biosimilar) Size:1 mg MMP9 degrades type IV andApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name VEGFR1 FLT1 Target Uniprot P17948 Overview Catalog# BIO0411SM Product Name Anti human VEGFR1 FLT1 (Abbott patent Anti Flt1 Biosimilar) Specifications Conjugation None Clone# Abbott patent Anti Flt1 Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with
US$ 39.95
US$ 20.00
US$ 35.00
![Desktop Punching Bag, [Upgrade, Flexibility] Boxing Bag Speed Balls Boxing High - Black color](https://cdn.shopify.com/s/files/1/0601/1355/1456/files/IMG-1734.jpg?v=1758275933)
US$ 18.00
US$ 28.00
US$ 35.95
US$ 26.00
US$ 26.00
US$ 39.95
US$ 15.00
US$ 19.95
